Latest Financing News

Atlantic Lithium has submitted a revised Mining Lease for its flagship Ewoyaa Lithium Project to Ghana's Parliament, aligning fiscal terms with current legislation and awaiting final ratification. Meanwhile, promising exploration results in Côte d’Ivoire and a successful capital raise underpin the company’s growth ambitions.

SIV Capital Limited posted a negative operating cash flow of $115,000 for the December quarter, maintaining a strong cash balance of nearly $8 million despite its securities suspension by ASX.

Australian Agricultural Projects Ltd reports steady orchard health and harvest expectations amid rising water prices, while strengthening its asset base and maintaining robust cashflow in the December 2025 quarter.

Heavy Rare Earths Limited has secured all-minerals rights at its Prospect Hill project, paving the way for a maiden tin resource estimate, while new data from Radium Hill reveals an 8km corridor rich in uranium and rare earth elements.

NuEnergy Gas Limited reported a cash outflow in Q4 2025 but secured a binding gas sales agreement and a strategic funding collaboration to advance its Indonesian coal bed methane projects.

NuEnergy Gas Limited has completed drilling four wells at its Tanjung Enim project, gearing up for initial gas sales in the first half of FY26. The company also inked key agreements to finance and expand its coal bed methane operations in Indonesia.

Brightstar Resources has released an updated Definitive Feasibility Study for its Goldfields Project, outlining a robust six-year production plan averaging 75,000 ounces of gold annually and a pre-tax NPV of A$606 million. The study highlights a new 1.5Mtpa processing plant with expansion potential and a clear pathway to first gold by mid-2027.

Brightstar Resources has released an updated feasibility study for its Goldfields Project, projecting $1 billion in pre-tax free cash flow and a 74% internal rate of return, setting the stage for a Final Investment Decision in March 2026.

Inhalerx Limited reported a $628,000 cash burn in the December quarter while securing substantial funding facilities to advance its clinical trials. The company’s cash position and financing arrangements suggest a runway extending over 80 quarters at current spending levels.

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

ASF Group Limited closed December 2025 with $1.91 million in cash and nearly four quarters of funding runway, while progressing key investments in mining, technology, and biotech sectors.

KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.